AIMCA
EGRX

Alberta Investment Management Corp (AIMCo)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,606
Closed -$342K – 1218
2023
Q2 		$342K Sell
17,606
-1,992
-10% -$47.3K ﹤0.01% 1025
2023
Q1 		$556K Hold
19,598
– – 0.01% 939
2022
Q4 		$573K Sell
19,598
-861
-4% -$27.4K 0.01% 904
2022
Q3 		$541K Buy
20,459
+4,632
+29% +$170K ﹤0.01% 1056
2022
Q2 		$703K Hold
15,827
– – 0.01% 986
2022
Q1 		$783K Buy
15,827
+7,714
+95% +$370K ﹤0.01% 1038
2021
Q4 		$413K Buy
+8,113
New +$420K ﹤0.01% 903
2020
Q3 		– Sell
-8,400
Closed -$403K – 1169
2020
Q2 		$403K Sell
8,400
-8,100
-49% -$404K ﹤0.01% 883
2020
Q1 		$759K Sell
16,500
-6,250
-27% -$314K 0.01% 634
2019
Q4 		$1.37M Sell
22,750
-15,450
-40% -$921K 0.01% 591
2019
Q3 		$2.16M Buy
38,200
+4,989
+15% +$281K 0.02% 484
2019
Q2 		$1.85M Buy
33,211
+8,911
+37% +$465K 0.02% 497
2019
Q1 		$1.23M Buy
24,300
+13,500
+125% +$601K 0.01% 567
2018
Q4 		$435K Sell
10,800
-5,200
-33% -$268K ﹤0.01% 707
2018
Q3 		$1.11M Sell
16,000
-6,500
-29% -$493K 0.01% 596
2018
Q2 		$1.7M Sell
22,500
-7,500
-25% -$472K 0.01% 484
2018
Q1 		$1.58M Sell
30,000
-52,700
-64% -$3.06M 0.01% 478
2017
Q4 		$4.42M Buy
82,700
+26,800
+48% +$1.49M 0.04% 366
2017
Q3 		$3.33M Buy
+55,900
New +$3.38M 0.03% 387

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s EGRX Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2023, closing a stake of 17,606 shares — an estimated $342K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in EGRX in Q3 2017 and held it in 19 quarters. The position peaked at $4.42M in Q4 2017. 107 funds tracked by Wall St. Rank hold EGRX as of Q3 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 17,606 Eagle Pharmaceuticals, Inc. shares in Q3 2023, an estimated $342K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2017 and held it in 19 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Eagle Pharmaceuticals, Inc. position peaked at $4.42M in Q4 2017.
  • 107 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.